BFEC
BIVV

Benjamin F. Edwards & Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Benjamin F. Edwards & Company’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed -$3K – 1731
2017
Q4 		$3K Hold
50
– – ﹤0.01% 1464
2017
Q3 		$3K Sell
50
-5
-9% -$293 ﹤0.01% 1432
2017
Q2 		$3K Hold
55
– – ﹤0.01% 1356
2017
Q1 		$3K Buy
+55
New +$2.71K ﹤0.01% 1261

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Benjamin F. Edwards & Company's BIVV Position: Q1 2018 in Review

Benjamin F. Edwards & Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 50 shares — an estimated $3K sold.

Benjamin F. Edwards & Company first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Benjamin F. Edwards & Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 50 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3K.
  • Benjamin F. Edwards & Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Benjamin F. Edwards & Company's Bioverativ Inc. Common Stock position peaked at $3K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2018, filed 17 Apr 2018.